171 related articles for article (PubMed ID: 21257057)
1. Glucagon-like peptide-2 (GLP-2) increases small intestinal blood flow and mucosal growth in ruminating calves.
Taylor-Edwards CC; Burrin DG; Holst JJ; McLeod KR; Harmon DL
J Dairy Sci; 2011 Feb; 94(2):888-98. PubMed ID: 21257057
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 2 therapy reduces negative effects of diarrhea on calf gut.
Connor EE; Kahl S; Elsasser TH; Baldwin RL; Fayer R; Santin-Duran M; Sample GL; Evock-Clover CM
J Dairy Sci; 2013 Mar; 96(3):1793-802. PubMed ID: 23312992
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-2 (GLP-2) increases net amino acid utilization by the portal-drained viscera of ruminating calves.
Taylor-Edwards CC; Burrin DG; Kristensen NB; Holst JJ; McLeod KR; Harmon DL
Animal; 2012 Dec; 6(12):1985-97. PubMed ID: 23031436
[TBL] [Abstract][Full Text] [Related]
4. The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients.
Bremholm L; Hornum M; Andersen UB; Hartmann B; Holst JJ; Jeppesen PB
Regul Pept; 2011 Jun; 168(1-3):32-8. PubMed ID: 21421014
[TBL] [Abstract][Full Text] [Related]
5. Loss of glucagon-like peptide-2-induced proliferation following intestinal epithelial insulin-like growth factor-1-receptor deletion.
Rowland KJ; Trivedi S; Lee D; Wan K; Kulkarni RN; Holzenberger M; Brubaker PL
Gastroenterology; 2011 Dec; 141(6):2166-2175.e7. PubMed ID: 21925122
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in the intestinal growth promoting effects of glucagon-like peptide 2 following intestinal resection.
Kaji T; Tanaka H; Redstone H; Wallace LE; Holst JJ; Sigalet DL
J Surg Res; 2009 Apr; 152(2):271-80. PubMed ID: 19062041
[TBL] [Abstract][Full Text] [Related]
7. The effects of variations in dose and method of administration on glucagon like peptide-2 activity in the rat.
Kaji T; Tanaka H; Holst JJ; Redstone H; Wallace L; de Heuval E; Sigalet DL
Eur J Pharmacol; 2008 Oct; 596(1-3):138-45. PubMed ID: 18762180
[TBL] [Abstract][Full Text] [Related]
8. Expression of mRNA for proglucagon and glucagon-like peptide-2 (GLP-2) receptor in the ruminant gastrointestinal tract and the influence of energy intake.
Taylor-Edwards CC; Burrin DG; Matthews JC; McLeod KR; Holst JJ; Harmon DL
Domest Anim Endocrinol; 2010 Oct; 39(3):181-93. PubMed ID: 20688461
[TBL] [Abstract][Full Text] [Related]
9. Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.
Washizawa N; Gu LH; Gu L; Openo KP; Jones DP; Ziegler TR
JPEN J Parenter Enteral Nutr; 2004; 28(6):399-409. PubMed ID: 15568286
[TBL] [Abstract][Full Text] [Related]
10. Effects of feeding vitamin A and lactoferrin on epithelium of lymphoid tissues of intestine of neonatal calves.
Schottstedt T; Muri C; Morel C; Philipona C; Hammon HM; Blum JW
J Dairy Sci; 2005 Mar; 88(3):1050-61. PubMed ID: 15738240
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide 2: a new treatment for chemotherapy-induced enteritis.
Tavakkolizadeh A; Shen R; Abraham P; Kormi N; Seifert P; Edelman ER; Jacobs DO; Zinner MJ; Ashley SW; Whang EE
J Surg Res; 2000 Jun; 91(1):77-82. PubMed ID: 10816354
[TBL] [Abstract][Full Text] [Related]
12. GLP-2 and mesenteric blood flow.
Hansen LB
Dan Med J; 2013 May; 60(5):B4634. PubMed ID: 23673268
[TBL] [Abstract][Full Text] [Related]
13. GLP-2alpha accelerates recovery of mucosal absorptive function after intestinal ischemia/reperfusion.
Prasad R; Alavi K; Schwartz MZ
J Pediatr Surg; 2001 Apr; 36(4):570-2. PubMed ID: 11283879
[TBL] [Abstract][Full Text] [Related]
14. The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice.
Dubé PE; Forse CL; Bahrami J; Brubaker PL
Gastroenterology; 2006 Aug; 131(2):589-605. PubMed ID: 16890611
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats.
Zhang W; Zhu W; Zhang J; Li N; Li J
Microsurgery; 2008; 28(4):285-90. PubMed ID: 18383347
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.
Martin GR; Wallace LE; Sigalet DL
Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-2 improves both acute and late experimental radiation enteritis in the rat.
Torres S; Thim L; Milliat F; Vozenin-Brotons MC; Olsen UB; Ahnfelt-Rønne I; Bourhis J; Benderitter M; François A
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1563-71. PubMed ID: 18035212
[TBL] [Abstract][Full Text] [Related]
18. [Protective effects of glucagon-like peptide 2 on intestinal ischemia/reperfusion injury in mice].
Guan LL; Gong DZ; Tian N; Zou Y
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 May; 21(2):192-4. PubMed ID: 21171341
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-2 protects impaired intestinal mucosal barriers in obstructive jaundice rats.
Chen J; Dong JT; Li XJ; Gu Y; Cheng ZJ; Cai YK
World J Gastroenterol; 2015 Jan; 21(2):484-90. PubMed ID: 25593463
[TBL] [Abstract][Full Text] [Related]
20. Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine.
Anini Y; Izzo A; Oudit GY; Backx PH; Brubaker PL
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1599-606. PubMed ID: 17284578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
